These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 18094350
1. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies. Gums JG, Boatwright DW, Camblin M, Halstead DC, Jones ME, Sanderson R. Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350 [Abstract] [Full Text] [Related]
3. [Carrier rate of Streptococcus pneumoniae and susceptibility thereof to antimicrobial drugs among children in China: a surveillance study in Beijing, Shanghai, and Guangzhou 2000-2002]. Yao KH, Lu Q, Deng L, Yu SJ, Zhang H, Deng QL, Shen XZ, Yang YH. Zhonghua Yi Xue Za Zhi; 2005 Jul 27; 85(28):1957-61. PubMed ID: 16313770 [Abstract] [Full Text] [Related]
11. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics. Moore LJ, Gilbey AM, Dowson CG, Pridmore AC, Dower SK, Read RC. J Antimicrob Chemother; 2007 Jan 27; 59(1):35-42. PubMed ID: 17079241 [Abstract] [Full Text] [Related]
12. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness. Soriano F, Cafini F, Aguilar L, Tarragó D, Alou L, Giménez MJ, Gracia M, Ponte MC, Leu D, Pana M, Letowska I, Fenoll A. J Antimicrob Chemother; 2008 Dec 27; 62(6):1234-40. PubMed ID: 18799472 [Abstract] [Full Text] [Related]
13. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain. Seral C, Suárez L, Rubio-Calvo C, Gómez-Lus R, Gimeno M, Coronel P, Durán E, Becerril R, Oca M, Castillo FJ. Diagn Microbiol Infect Dis; 2008 Oct 27; 62(2):210-5. PubMed ID: 18715733 [Abstract] [Full Text] [Related]
14. Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation. Frei CR, Burgess DS. Pharmacotherapy; 2005 Sep 27; 25(9):1161-7. PubMed ID: 16164390 [Abstract] [Full Text] [Related]
15. Antibiotic susceptibility of Streptococcus pneumoniae in New Zealand. Brett W, Masters PJ, Lang SD, Ikram RB, Hatch SH, Gordon MS. N Z Med J; 1999 Mar 12; 112(1083):74-8. PubMed ID: 10210308 [Abstract] [Full Text] [Related]
16. Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae--United States, 2003. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2004 Feb 27; 53(7):152-4. PubMed ID: 14985653 [Abstract] [Full Text] [Related]
18. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime. Karlowsky JA, Jones ME, Draghi DC, Sahm DF. Antimicrob Agents Chemother; 2003 Oct 27; 47(10):3155-60. PubMed ID: 14506024 [Abstract] [Full Text] [Related]
19. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis. Fernández A, Cabellos C, Tubau F, Maiques JM, Doménech A, Ribes S, Liñares J, Viladrich PF, Gudiol F. J Antimicrob Chemother; 2005 Jan 27; 55(1):78-83. PubMed ID: 15546968 [Abstract] [Full Text] [Related]
20. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV. Clin Infect Dis; 2009 Feb 01; 48(3):e23-33. PubMed ID: 19115971 [Abstract] [Full Text] [Related] Page: [Next] [New Search]